TransCode pays Yorkville $840,975 and obtains waiver after stock falls below $1.72 Floor Price

Transcode Therapeutics, Inc.

On October 1, 2026, TransCode and Yorkville executed a waiver; TransCode made a $840,975 prepayment including $759,000 principal, $75,900 premium, and $6,075 accrued interest.
The daily VWAP of TransCode common stock was below the $1.72 Floor Price for 10 of 14 trading days from September 11, 2026 to September 30, 2026, triggering an Amortization Event.
Yorkville waived Amortization Events deemed to occur on or before September 30, 2026 and through October 31, 2026; remaining Convertible Note principal is about $4.1 million.
Under the Convertible Notes, an Amortization Event requires monthly payments of 18% of outstanding principal plus 10% of principal paid and accrued interest until repayment or cure.
The SEPA with YA II PN, Ltd. allows TransCode to sell up to $14 million of common stock; Yorkville also agreed to advance up to $6.0 million via convertible notes.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.